Marimed (MRMD) Tax Provisions (2018 - 2026)

Marimed (MRMD) has 9 years of Tax Provisions data on file, last reported at $2.7 million in Q1 2026.

• Tax Provisions for Q1 2026 came in at $2.7 million, down 6.36% year-over-year; the trailing twelve-month figure through Mar 2026 was $3.4 million (down 63.29% YoY), and the FY2025 annual result was $3.6 million, down 55.95% from the prior year.
• Tax Provisions rose to $2.7 million in Q1 2026 per MRMD's latest filing, from -$2.7 million in the prior quarter.
• Over five years, Tax Provisions peaked at $4.9 million in Q4 2024 and troughed at -$2.7 million in Q4 2025.
• A 5-year average of $1.7 million and a median of $1.9 million in 2023 frame the typical range for Tax Provisions.
• The sharpest annual moves came in 2024 and 2025: Tax Provisions soared 872.1% in 2024, then slumped 154.3% in 2025.
• A 5-year view of Tax Provisions shows it stood at -$2.0 million in 2022, then surged by 125.45% to $509000.0 in 2023, then soared by 872.1% to $4.9 million in 2024, then tumbled by 154.3% to -$2.7 million in 2025, then jumped by 198.66% to $2.7 million in 2026.
• Business Quant data shows MRMD's Tax Provisions at $2.7 million in Q1 2026, -$2.7 million in Q4 2025, and $2.8 million in Q3 2025.